Tetracycline-regulated secretion of human (pro)insulin following plasmid-mediated transfection of human muscle

Journal of Molecular Endocrinology

Volumn 34, Issue 2, 2005, Pages 391-403

  Wilson, Magdalene O ^a   Scougall, Kathleen T ^a   Ratanamart, Jarupa ^a   McIntyre, Elizabeth A ^a   Shaw, James A M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; INSULIN; LIPOSOME; PREPROINSULIN; PROINSULIN; TETRACYCLINE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIABETES MELLITUS; DRUG SAFETY; DRUG TOLERABILITY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INCUBATION TIME; INSULIN RELEASE; INSULIN SYNTHESIS; MOUSE; MYOBLAST; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; RAT; WILD TYPE;

ADULT; ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; GENE EXPRESSION REGULATION; GENE THERAPY; GENES, REPORTER; HUMANS; INSULIN; MICE; MUSCLE, SKELETAL; PLASMIDS; PROINSULIN; RATS; RATS, WISTAR; TETRACYCLINE; TRANSFECTION;

EID: 17844376247     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01646     Document Type: Article

References (29)

1. Abai AM, Hobart PM & Barnhart KM 1999 Insulin delivery with plasmid DNA. Human Gene Therapy 10 2637-2649.
2. Belles-Isles M, Roy R, Dansereau G, Goulet M, Roy B, Bouchard JP & Tremblay JP 1993 Rapid selection of donor myoblast clones for muscular dystrophy therapy using cell surface expression of NCAM. European Journal of Histochemistry 37 375-380.
3. Blau HM & Webster C 1981 Isolation and characterization of human muscle cells. PNAS 78 5623-5627.
4. Croze F & Prud'homme GJ 2003 Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes Journal of Gene Medicine 5 425-437.
5. Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329 977-986.
6. Fiorina P, La Rocca E, Venturini M, Minicucci F, Fermo I, Paroni R, Angelo A Sblendido M, Carlo VD, Cristallo M, Maschio AD, Pozza G & Secchi A 2001 Eifects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and Type 1 diabetes. Diabetes 50 496-501.
7. Gene Therapy Clinical Trials online database (www.wiley.co.uk./genetherapy) accessed 23-04-04.
8. Halse R, Rochford JJ, McCormack JG, Vandenheede JR, Hemmings BA & Yeaman SJ 1999 Control of glycogen synthesis in cultured human muscle cells. Journal of Biological Chemistry 274 776-780.
9. Hartikka J, Sawdey M, Cornefert-Jensen F, Margalith M, Barnhart K, Nolasco M, Vahlsing HL, Meek J, Marquet M, Hobart P, Norman J & Manthorpe M 1996 An improved plasmid DNA expression vector for direct injection into skeletal muscle. Human Gene Therapy 7 1205-1217.
10. Hay CW & Docherty K 2003 Enhanced expression of a furin-cleavable proinsulin. Journal of Molecular Endocrinology 31 597-607.
11. Horton HM, Anderson D, Hernandez P & Barnhart KM 1999 A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha. PNAS 96 1553-1558.
12. Kawakami Y, Yamaoka T, Hirochika R, Yamashita K, Itakura M & Nakauchi H 1992 Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells. Diabetes 41 956-961.
13. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Trygvasson K & Martin GR 1982 Isolation and characterization of type IV procollagen, laminin and heparan sulfate proteoglycan from the EHS sacroma. Biochemistry 24 6188-6193.
14. Kon OL, Sivakumar S, Teoh KL, Lok SH & Long YC 1999 Naked plasmid-mediated gene transfer to skeletal muscle ameliorates diabetes mellitus. Journal of Gene Medicine 1 186-194.
15. Martinenghi S, Cusella De Angelis G, Biressi S, Amadio S, Bifari F, Roncarolo MG, Bordignon C & Falqui L 2002 Human insulin production and amelioration of diabetes in mice by electrotransfer-enhanced plasmid DNA gene transfer to the skeletal muscle. Gene Therapy 9 1429-1437.
16. Owens DR, Zinman B & Bolli GB 2001 Insulins today and beyond. Lancet 358 739-746.
17. Rees S, Coote J, Stables J, Goodson S, Harris S & Lee MG 1996 Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotics-resistant cells to express recombinant protein. BioTechniques 20 102-110.
18. Riddle MC, Rosenstock J & Gerich J 2003 The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26 3080-3086.
19. Rivera VM, Wang X, Wardwell S, Courage NL, Volchuk A, Keenan T, Holt DA, Gilman M, Orci L, Cerasoli F Jr, Rothman JE & Clackson T 2000 Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum. Science 287 826-830.
20. Ryan EA, Lakey JRT & Paty BW 2002 Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51 2148-2157.
21. Scougall KT & Shaw JAM 2003 Tetracycline-regulated secretion of human insulin in transfected primary myoblasts. Biochemical and Biophysical Research Communications 304 167-175.
22. Scougall KT, Maltin CA & Shaw JM 2003 Tetracycline-regulated secretion of human insulin in transfected non-endocrine cell line. Journal of Molecular Endocrinology 30 331-346.
23. Shaw JAM & Docherty K 2002 Genetic engineering in the treatment of diabetes. In Oxford Textbook of Endocrinology and Diabetes, pp 1866-1872. Eds J Wass & S Shalet. Oxford, UK: Oxford University Press.
24. Shaw JAM, Delday MI, Hart AW & Docherty K 2002 Secretion of bioactive human insulin following plasmid-mediated gene transfer to non-neuroendocrine cell lines, primary cultures, and rat skeletal muscle in vivo. Journal of Endocrinology 72 653-672.
25. Simonson GD, Groskreutz DJ, Gorman CM & MacDonald MJ 1996 Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Human Gene Therapy 7 71-78.
26. Tripathy SK, Svensson EC, Black HB, Goldwasser E, Margalith M., Hobart PM & Leiden JM 1996 Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. PNAS 93 10876-10880.
27. UK Prospective Diabetes Study Group 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes. Lancet 352 837-853.
28. Wolff JA, Ludtke JJ, Acsadi G, Williams P & Jani A 1992 Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Human Molecular Genetics 1 363-369.
29. Yamasaki K, Takashi S, Nemoto M, Eto Y & Tajima N 1999 Differentiation-induced insulin secretion from nonendocrine cells with engineered human proinsulin cDNA. Biochemical and Biophysical Research Communications 265 361-365.